The Diagnostic Pitfall: DOACs and Activated Partial Thromboplastin Time
Mohamed Hanafy Morsy, Associate Professor of Clinical Pathology, Hematopathologist at Makkah Health Cluster, posted on LinkedIn:
”Lab staff + Cardiology Colleagues – Quick 30-second read that will save you confusion forever
The Diagnostic Pitfall: Direct Oral Anticoagulants (DOACs) and Activated Partial Thromboplastin Time (aPTT)
Scenario: A patient is receiving therapeutic anticoagulation with a direct Factor Xa inhibitor (e.g., Apixaban, Rivaroxaban). Routine or emergent coagulation screening returns an aPTT result that is unmeasurably short, <25 seconds, or within the institutional reference interval.
Your reaction?
A) Panic – “The patient has NO anticoagulation”
B) Call the lab – “Your machine is broken”
C) Relax – This is 100 % normal and expected
The correct answer is C
Apixaban (and all DOACs) have minimal to no effect on aPTT.
A super-low aPTT does NOT mean the drug isn’t working.
Ideal lab comment to add automatically when apixaban is on the chart:
“The aPTT result is not validated for assessing the efficacy of Direct Factor Xa Inhibitors. If quantitative assessment of drug concentration is required, order the drug-specific Chromogenic Anti-Xa Assay.”
Let’s stop the 2 a.m. pages to hematology for this.”
Keep up with Hemostasis Today.
-
Sep 30, 2026, 15:58Bernhard Merget: New Frontiers in Thrombosis and Stroke Research
-
Sep 30, 2026, 15:39Ifeanyichukwu Ifechidere: The Molecular Orchestra of Primary Hemostasis
-
Sep 30, 2026, 15:28Reassessing the Benefit–Risk Balance of Extended Anticoagulation in Cancer Patients – ESC Working Group on Cardiovascular Pharmacotherapy
-
Sep 30, 2026, 15:07Chiranjeev Sharma: Targeting Factor XIa with the Synthetic Inhibitor SB-01
-
Sep 30, 2026, 14:41Bruna Gigante: Balancing Thrombosis and Bleeding in Cardiovascular Care
-
Sep 30, 2026, 14:13Ashok Choudhury: Portal Vein Thrombosis and Outcomes in Cirrhosis
-
Sep 30, 2026, 13:57Leslye Conde Bazán: When Conventional Imaging Is Not Enough – The Role of IVUS
-
Sep 30, 2026, 13:41Huda Salah Eldin: The Challenge of Balancing Antithrombotic Therapy After PCI
-
Sep 30, 2026, 13:29Abdus Salam: What Can CT Venography Reveal About the Veins?